Table 1 Epidemiological and clinical characteristics of the 2,609 Spanish patients with rheumatoid arthritis included in the study.

From: Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis

Clinical Feature

% (n/N)

Age at the time of disease onset (years, mean ± standard deviation)

50.8 ± 14.7

Follow-up (years, mean ± standard deviation)

12.7 ± 8.6

Percentage of women

76.4

Rheumatoid factor positive *

64.7 (1,433/2,213)

Anti-CCP antibodies positive

59.2 (1,333/2,251)

Erosions

53.1 (1,162/2,186)

Extra-articular manifestations †

24.7 (444/1,799)

Cardiovascular risk factors

 

Hypertension

37.9 (934/2,462)

Diabetes mellitus

12.5 (308/2,462)

Dyslipidemia

37.9 (935/2,462)

Obesity

21.2 (522/2,462)

Smoking habit

37.0 (911/2,462)

Patients with cardiovascular events

15.7 (410/2,609)

Ischemic heart disease

6.8 (179/2,609)

Heart failure

5.7 (149/2,609)

Cerebrovascular accident

4.5 (118/2,609)

Peripheral arteriopathy

1.9 (51/2,609)

  1. Anti-CCP antibodies: Anti-cyclic citrullinated peptide antibodies.
  2. *At least two determinations were required.
  3. †If patients experienced: nodular disease, Felty’s syndrome, pulmonary fibrosis, rheumatoid vasculitis, or secondary Sjögren’s syndrome.
Back to article page